2030 年机器人辅助手术系统市场报告(按细分市场、地域、动态、最新发展和战略见解)

  • Report Code : TIPRE00004753
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Robotic Assisted Surgery Systems Market Size Report |Share, Growth Drivers & Global Outlook 2030

Buy Now

【研究报告】机器人辅助手术系统市场规模预计将从2022年的78.3193亿美元增长到2030年的238.168亿美元;预计 2022 年至 2030 年该市场的复合年增长率将达到 14.9%。
市场洞察和分析师观点:
机器人辅助手术系统市场包含一系列技术先进的手术平台,这些平台集成了机器人、成像和导航帮助外科医生以更高的精度和控制执行微创手术的系统。这些系统旨在增强手术能力、改善患者治疗效果并最大限度地减少传统手术技术的侵入性。机器人辅助手术系统的显着优点包括增强的灵活性、三维可视化和震颤过滤,使外科医生能够以卓越的准确性和可操作性执行复杂的手术。这些系统通常使他们能够进入难以到达的解剖区域,从而减少创伤并加快患者康复时间。此外,机器人技术在手术中的集成可最大程度地降低并发症风险并降低输血需求,最终有助于改善术后结果。
增长动力和挑战:
越来越多的研究探索其好处机器人辅助操作的能力预计将在未来几年推动市场进步。 2022 年 9 月,名古屋市立大学 (NCU) 医学研究生院的一个团队进行了一项研究,比较机器人辅助、荧光镜引导、超声引导下的肾脏通路进行经皮肾镜取石术。该研究的结果证明了革命性机器人设备的安全性和易用性,这可能会减轻外科医生的培训负担,并使更多的医院能够执行 PCNL 手术。这种方法使用人工智能驱动的机器人技术,可能为类似外科手术的自动化打开一扇大门,从而加快手术过程并降低并发症的风险。
慢性病病例的增加和日益普及微创手术的发展进一步有利于机器人辅助手术系统市场。据《印度教徒报》2022 年 8 月发布的消息,印度海得拉巴的阿波罗健康城已完成 500 多例机器人辅助妇科手术。 2022 年 11 月,美敦力公司全资子公司印度美敦力私人有限公司 (India Medtronic Private Limited) 与德里 Venkateshwar 医院宣布,利用 Hugo 机器人辅助手术 (RAS) 系统完成了印度北部首例泌尿外科治疗。
另一方面,机器人手术系统的高成本阻碍了医疗保健提供者的财务可行性和运营可持续性。虽然这些系统具有提高精度、微创和缩短患者康复时间等优点,但大量的前期投资和持续的维护成本需要对医疗机构进行仔细的财务规划和资源分配。此外,手术人员操作这些系统需要专门的培训和认证,这进一步增加了运营成本,影响了将机器人手术整合到现有临床实践中的整体承受能力和实用性。与机器人手术系统相关的成本负担有可能影响医疗报销模式和承保决策。使用机器人辅助进行的手术的报销率可能会有所不同,保险公司的承保范围可能会影响采用这些技术的经济理由。这就造成了一个复杂的局面,医疗机构需要权衡机器人手术的临床优势和财务影响,这可能会影响不同医疗系统的采用速度和规模。

报告细分和范围:
机器人辅助手术系统市场根据产品类型、应用和最终用户进行细分。根据产品类型,市场分为系统、仪器和配件以及服务。按应用划分,机器人辅助手术系统市场分为妇科手术、心血管、神经外科、骨科手术、腹腔镜、泌尿外科、普通外科等。该市场根据最终用户分为医院、门诊手术中心和其他最终用户。从地域来看,机器人辅助手术系统市场分为北美(美国、加拿大和墨西哥)、欧洲(英国、德国、法国、意大利、西班牙和欧洲其他地区)、亚太地区(中国、日本、印度、韩国、澳大利亚和亚太地区其他地区)、中东和非洲(阿联酋、沙特阿拉伯、南非以及中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南方其他地区)和中美洲)。
细分市场分析:
根据产品类型,手术机器人细分市场在 2022 年将在机器人辅助手术系统市场中占据可观的收入份额。手术机器人执行精确手术的需求是由于心血管和癌症疾病的全球发病率激增,预计这一数字将会增加。根据美国癌症协会的《2023 年癌症统计》,预计美国将在 2023 年报告 190 万个新癌症病例。根据澳大利亚健康与福利研究所 (AIHW) 的 2021 年报告,澳大利亚 2021 年估计的新癌症病例为150,800。澳大利亚统计局 2022 年 3 月的报告指出,预计 2021 年将有 4.0% 的澳大利亚人(即 100 万人)患有心脏病。
按产品类型划分的机器人辅助手术系统市场 – 2022 年和 2030 年
根据应用,机器人辅助手术系统市场分为妇科手术、心血管手术、神经外科、骨科手术、腹腔镜手术、泌尿外科、普外科等。神经病学领域预计在 2022 年至 2030 年期间将创下最快的复合年增长率。手术机器人在普通手术中的使用越来越多,及其相对于传统手术方法的优势使整个市场受益。此外,技术的进步和机器人神经外科手术的成功结果预计将在未来几年推动机器人辅助手术系统市场的扩张。根据 SS Innovations Interventional Inc. 的数据,2020 年全球约有 160 万例机器人手术。
按最终用户划分,机器人辅助手术系统市场分为医院、门诊手术中心和其他最终用户。医院细分市场在 2022 年占据市场主导地位,预计 2022 年至 2030 年复合年增长率将很高。医院市场的增长归因于多个经济体医疗成本的上升。医院利用最新的机器人辅助手术设备提供优质的护理。此外,内科医生和外科医生更喜欢机器人辅助系统。根据 JAMA 网络发表的一篇论文,机器人辅助手术在整体外科手术中的使用率从 2013 年的 1.8% 激增至 2019 年的 15.1%。
区域分析:
基于地理位置,机器人辅助手术手术系统市场分为北美、欧洲、亚太地区、中东和非洲、以及南美洲和中美洲。北美是该市场增长的最重要贡献者。该地区的市场进步归因于美国自动化手术器械的不断使用和下一代医疗保健系统的采用。此外,与患者人数相比,美国缺乏外科医生和医疗专业人员,预计这将使机器人辅助手术系统市场受益。糖尿病、癌症和心血管疾病等慢性病患病率的增加推动了美国对机器人辅助手术系统的需求。
与传统手术相比,微创手术的日益普及有利于机器人辅助手术系统市场。据美敦力公司称,2022 年 12 月,Hugo 在美国扩展了其机器人辅助手术 (RAS) 系统的临床试验,招募了第一位患者。此外,2022 年,北卡罗来纳州达勒姆杜克大学医院的一名医生进行了机器人辅助前列腺切除术。
由于患者人数的不断增长以及复杂的自动化手术器械的使用不断增加。此外,扩大现代医疗设施和提高公众对尖端医疗技术优势的认识预计将有利于该地区未来的市场增长。亚太地区各国政府正在尝试建立先进的医疗基础设施,这吸引了国际企业在该地区投资建立自动化仪器开发设施。中国在亚太地区机器人辅助手术系统市场中占有最大份额,而印度预计在 2022-2030 年期间将创下最高复合年增长率。中国的手术机器人业务公司利用特殊审批途径加快了创新医疗产品的监管审批,缩短了上市时间。此外,该国正在涌现越来越多专门从事手术机器人技术的医疗科技公司。近年来,健嘉机器人和Hurwa进入中国市场,与国内专业骨科手术机器人公司TINAVI一起开发手术机器人解决方案。北京市报销 TINAVI 机器人辅助手术的脊柱、髋关节和膝关节手术。
行业发展和未来机遇:
全球机器人辅助手术系统市场主要参与者采取的各种举措如下:
2023 年 10 月,DePuy Synthes 旗下骨科业务强生 MedTech 推出了 VELYS 机器人辅助解决方案。该解决方案已在德国、比利时和瑞士的全膝关节置换手术中使用。通过此次发布,DePuy Synthes 扩展了其数字手术平台内的网络技术,以满足骨科机器人未满足的需求。2022 年 11 月,一家印度医疗科技企业与在纳斯达克上市的美国公司 Avra Medical Robotics 合作。第一个完全“印度制造”的手术机器人 SSI Mantra 由 SS Innovations 推出。它是高度发达的手术机器人系统,比市场上其他系统具有更多的功能和应用。2022年11月,美国FDA批准了Accelus的Remi机器人导航系统软件更新,该系统允许外科医生进行腰椎固定以放置椎弓根在机器人协助下拧螺丝。 Accelus 是一家私营医疗技术公司,专注于采用微创手术 (MIS) 作为脊柱护理标准。竞争格局和主要公司:
Intuitive Surgical Inc.、Stryker Corporation、Johnson & Johnson Inc. 、SRI International Inc.、Accuray Incorporated、Renishaw PLC、Medtronic PLC、Brainlab、Smith & Nephew PLC、Globus Medical 和 Zimmer Biomet 是机器人辅助手术系统市场的知名参与者。这些公司专注于扩大产品范围,以满足全球不断增长的消费者需求。他们的全球业务使他们能够为大量客户提供服务,从而扩大他们的市场份额。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the major players in the robotic assisted surgery systems market?

The robotic assisted surgery systems market has major market players, including Intuitive Surgical Inc., Stryker Corporation, Johnson & Johnson Inc., SRI International Inc., Accuray Incorporated, Renishaw PLC, Medtronic PLC, Brainlab, Smith & Nephew PLC, Globus Medical, and Zimmer Biomet.

Which type segment dominates the robotic assisted surgery systems market?

Based on product type, the surgical robot segment held a substantial revenue share of the robotic assisted surgery systems market in 2022. The need for surgical robots to perform precise and accurate procedures is predicted to increase due to the surging global incidence of cardiovascular and cancer disorders. The US is expected to report 1.9 million new cancer cases in 2023, according to the American Cancer Society's Cancer Statistics 2023. As per the Australian Institute of Health and Welfare's (AIHW) 2021 report, the estimated new cases of cancer in Australia in 2021 were 150,800. The March 2022 report from the Australian Bureau of Statistics states that 4.0% of Australians, or 1.0 million people, were estimated to have heart disease in 2021.

What factors drive the robotic assisted surgery systems market?

Growing preference for robotically assisted treatments, rising inclination toward minimally invasive surgeries, and the increasing number of product launches are the key factors driving the robotic assisted surgery systems market progress. However, the stringent regulatory processes and high cost of devices hinder the robotic assisted surgery systems market growth.

What was the estimated robotic assisted surgery systems market size in 2022?

The robotic assisted surgery systems market was valued at US$ 7,831.93 million in 2022.

What are the growth estimates for the robotic assisted surgery systems market till 2030?

The robotic assisted surgery systems market is expected to be valued at US$ 23,816.80 million in 2030.

What is robotic assisted surgery systems?

The robotic assisted surgery systems market encompasses an array of technologically advanced surgical platforms that integrate robotics, imaging, and navigation systems to assist surgeons in performing minimally invasive procedures with increased precision and control. These systems are designed to enhance surgical capabilities, improve patient outcomes, and minimize the invasiveness of traditional surgical techniques.

Which application type segment dominates the robotic assisted surgery systems market?

Based on application, the robot-assisted surgical systems market is classified into gynecological surgery, cardiovascular, neurosurgery, orthopedic surgery, laparoscopy, urology, general surgery, and others. The neurology sector is expected to record the fastest CAGR during 2022–2030. The increasing usage of surgical robots in general surgeries and the benefits they offer over conventional surgical methods benefit the overall market. Furthermore, improvements in technology and the successful results of robotic neurosurgery are anticipated to propel the expansion of the robot-assisted surgical systems market in the coming years. According to SS Innovations Interventional Inc., approximately 1.6 million robotic surgeries were performed globally in 2020.

The List of Companies - Robotic Assisted Surgery Systems Market 

  1. Intuitive Surgical Inc.
  2. Stryker Corporation
  3. Johnson & Johnson Inc.
  4. SRI International Inc.
  5. Accuray Incorporated
  6. Renishaw PLC
  7. Medtronic PLC
  8. Brainlab
  9. Smith & Nephew PLC
  10. Globus Medical
  11. Zimmer Biomet

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Medical Device : READ MORE..